{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:40:52Z","timestamp":1790872852283,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":5213,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1111\/j.1538-7836.2008.03070.x","type":"journal-article","created":{"date-parts":[[2008,7,5]],"date-time":"2008-07-05T21:34:36Z","timestamp":1215293676000},"page":"1571-1577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential"],"prefix":"10.1016","volume":"6","author":[{"given":"M.","family":"COLUCCI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"CATTANEO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"MARTINELLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"SEMERARO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.M.","family":"BINETTI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"SEMERARO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0010","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta\u2010analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0015","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1538-7836.2005.01141.x","article-title":"Homocysteine, MTHFR and risk of venous thrombosis: a meta\u2010analysis of published epidemiological studies","volume":"3","author":"Den Heijer","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0020","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1055\/s-2006-951456","article-title":"Hyperhomocysteinemia and venous thromboembolism","volume":"32","author":"Cattaneo","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0025","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1160\/TH05-05-0313","article-title":"Homocysteine and thrombosis: from basic science to clinical evidence","volume":"94","author":"Undas","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0030","doi-asserted-by":"crossref","first-page":"872","DOI":"10.5858\/2007-131-872-HATAO","article-title":"Hyperhomocysteinemia and thrombosis: an overview","volume":"131","author":"Eldibany","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0049-3848(93)90153-F","article-title":"Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters","volume":"70","author":"Bienvenu","year":"1993","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0040","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/01.STR.30.5.974","article-title":"Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke","volume":"30","author":"Kristensen","year":"1999","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0045","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1055\/s-0037-1613305","article-title":"Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk","volume":"88","author":"Tofler","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0050","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0049-3848(00)00324-8","article-title":"Mild hyperhomocysteinemia and fibrinolytic factors in patients with history of venous thromboembolism","volume":"100","author":"Bozic","year":"2000","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0055","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1055\/s-0038-1655990","article-title":"Mild hyperhomocysteinemia and hemostatic factors in patients with arterial vascular diseases","volume":"77","author":"Freyburger","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1042\/cs1000127","article-title":"Effects of acute methionine loading and vitamin C on endogenous fibrinolysis, endothelium\u2010dependent vasomotion and platelet aggregation","volume":"100","author":"Labinjoh","year":"2001","journal-title":"Clin Sci"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0049-3848(02)00191-3","article-title":"Effects of homocysteine thiol group on fibrin networks: another possible mechanism of harm","volume":"107","author":"Lauricella","year":"2002","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/01.mbc.0000220238.99843.45","article-title":"Influence of homocysteine on fibrin network lysis","volume":"17","author":"Lauricella","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0075","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1538-7836.2003.00053.x","article-title":"Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia","volume":"1","author":"Sauls","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0080","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/01.ATV.0000219688.43572.75","article-title":"Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects","volume":"26","author":"Undas","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0085","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1161\/01.ATV.20.12.2511","article-title":"Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway","volume":"20","author":"Bajzar","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0090","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1538-7836.2004.00605.x","article-title":"Carboxypeptidase U (TAFIa) prevents lysis from proceeding into the propagation phase through a threshold\u2010dependent mechanism","volume":"2","author":"Leurs","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0049-3848(97)00013-3","article-title":"Absence of hyperhomocysteinemia in ten patients with primary pulmonary hypertension","volume":"85","author":"Zighetti","year":"1997","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0100","first-page":"89","article-title":"Determination of total homocysteine in plasma: comparison of the Abbott Imx immunoassay with high performance liquid chromatography","volume":"87","author":"Zighetti","year":"2002","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0105","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1182\/blood-2003-02-0443","article-title":"Hyperhomocysteinemia in cerebral thrombosis","volume":"102","author":"Martinelli","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0110","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1182\/blood-2003-06-2169","article-title":"Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI\u2010mediated mechanism","volume":"103","author":"Colucci","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0115","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1182\/blood.V88.6.2093.bloodjournal8862093","article-title":"The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI\u2010dependent","volume":"88","author":"Bajzar","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0120","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-0037-1613199","article-title":"Effect of heparin on TAFI\u2010dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot\u2010bound and fluid phase thrombin","volume":"88","author":"Colucci","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2005-872405","article-title":"Homocysteine and methionine metabolism in renal failure","volume":"5","author":"Van Guldener","year":"2005","journal-title":"Semin Vasc Med"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0130","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1160\/TH03-06-0377","article-title":"Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration\u2010dependent manner. Study of seven plasminogen activators in an internal clot lysis model","volume":"91","author":"Guimar\u00e3es","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/gast.2001.25481","article-title":"Thrombin\u2010activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis","volume":"121","author":"Lisman","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0140","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00062752-199603050-00010","article-title":"Thrombin\u2010dependent inhibition of fibrinolysis","volume":"3","author":"Broze","year":"1996","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0950-3536(05)80268-9","article-title":"Mechanisms of physiological fibrinolysis","volume":"8","author":"Lijnen","year":"1995","journal-title":"Baillieres Clin Haematol"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0150","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/s-0037-1613441","article-title":"Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasma","volume":"89","author":"Leurs","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0155","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1055\/s-0037-1614500","article-title":"The elevated risk for venous thrombosis in persons with hyperhomocysteinemia is not reflected by the endogenous thrombin potential","volume":"81","author":"Bos","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0049-3848(03)00242-1","article-title":"Homocysteine and hemostatic disorder as a risk factor for myocardial infarction at a young age","volume":"109","author":"Ogawa","year":"2003","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0165","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2006-04-014654","article-title":"Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo\u2010controlled, double\u2010blind trial","volume":"109","author":"Den Heijer","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0170","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-146-11-200706050-00157","article-title":"Homocysteine\u2010lowering therapy and risk for venous thromboembolism: a randomized trial","volume":"146","author":"Ray","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0175","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.seminhematol.2007.01.002","article-title":"Hyperhomocysteinemia and venous thrombosis","volume":"44","author":"Gatt","year":"2007","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0180","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1160\/TH06-12-0715","article-title":"Fibrin clot structure in patients with end\u2010stage renal disease","volume":"98","author":"Sj\u00f8land","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0185","first-page":"34","article-title":"Fibrinolysis in chronic renal failure, dialysis and renal transplantation","volume":"7","author":"Opatrn\u00fd","year":"2002","journal-title":"Ann Transplant"},{"key":"10.1111\/j.1538-7836.2008.03070.x_bb0190","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1159\/000082862","article-title":"Comparison of effects of different heparins on thrombin activatable fibrinolysis inhibitor in hemodialyzed patients","volume":"24","author":"Ma\u0142yszko","year":"2004","journal-title":"Am J Nephrol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2008.03070.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622132551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622132551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2008.03070.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:46:33Z","timestamp":1761533193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622132551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1538783622132551"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03070.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03070.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}